Bohlin Garen G insider trades
Bohlin Garen G has filed 12 Form 4s with the SEC that we hold, for Collegium Pharmaceutical, INC (COLL) (Director) and Karyopharm Therapeutics Inc. (KPTI) (Director). Across all of them we count 1 purchase worth $50.2K and 2 sales worth $1.3M reported on Form 4. In the last 12 months: 0 purchases ($0) and 1 sale ($323.5K). The largest single trade was a sale of 28,985 shares of Collegium Pharmaceutical, INC worth $936.2K, dated 2024-05-14. The first filing on our record is dated 2022-05-20 and the latest 2026-05-26.
Collegium Pharmaceutical, INC (COLL)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2024-05-14 | S, sale reported on Form 4 | 28,985 | $936.2K | 2024-05-16 |
| 2026-05-11 | S, sale reported on Form 4 | 8,700 | $323.5K | 2026-05-13 |
Karyopharm Therapeutics Inc. (KPTI)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2023-09-12 | P, purchase reported on Form 4 | 41,140 | $50.2K | 2023-09-12 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1254705) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms